Dividends Calendar Earnings Calendar
EDIT

EDIT | Editas

Healthcare sector
Editas
Category: Pharmaceutical company
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 2.63B
  • Prev closed: 81.6
  • Open: 82.12
  • High: 87.89
  • Low: 80.59
  • 52 week low: 14.01
  • 52 week high: 96.45
  • Dividends:No Dividends

Next ER: May 5, 2021  Before Market Opens



Top Stories (EDIT)



    About the Company

    Editas Medicine is a discovery-phase pharmaceutical company based in Cambridge, Massachusetts which aims to develop therapies based on CRISPR–Cas9 gene editing technology. The company went public on 2 Feb 2016.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    August 10, 2021
    May 5, 2021-0.86 / -0.75736.5M / 5.78MBeat!
    February 25, 2021-1 / -0.7611.42M / 5.64MBeat!
    November 5, 20200.12 / -0.62662.84M / 6.36MBeat!
    August 6, 2020-0.43 / -0.7910.75M / 6.34MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Jun 15, 2021 35.29 38.34
    38.34
    35.08
    		 881.76K -8.41%
    Jun 14, 2021 38.53 37.78
    38.88
    37.41
    		 1.15M 2.97%
    Jun 11, 2021 37.42 37.54
    38.25
    36.61
    		 1.03M 1.41%
    Jun 10, 2021 36.90 36.05
    37.23
    35.29
    		 1.21M 1.37%
    Jun 9, 2021 36.40 36.59
    38.49
    36.37
    		 1.70M 1.14%
    Jun 8, 2021 35.99 36.23
    36.57
    34.17
    		 894.67K 1.35%
    Jun 7, 2021 35.51 33.98
    36.34
    33.32
    		 1.18M 5.46%
    Jun 4, 2021 33.67 34.00
    34.76
    33.45
    		 817.02K 0.93%
    Jun 3, 2021 33.36 34.71
    34.87
    32.71
    		 1.25M -4.79%
    Jun 2, 2021 35.04 34.00
    35.08
    33.76
    		 854.19K 2.40%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2013
    • Employees:89

    News

    News for (EDIT)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Katrine S. Bosley

    Talk about Editas below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on May 5, 2021 (Same day)

    znga gm gddy ctsh pypl cern fox edit meli dnow apa cf 


    Jump to (Finance sites)

    Google     
             

    Research 


    Investor page

    ir.editasmedicine.com

    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 40
    HOLD 40
    SELL 20

    Their Official Profiles 

    WikipediaTwitterLinkedIn

    Peers / Similar stocks 

    xlv 

    Other stocks 

    pg orcl wfc hrl rost wmb sptn schw bkng ostk tal mrvl 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Technical Analysis For Dummies
    Buy on Amazon

    Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.

    A simple, straightforward guide to the fundamentals of technical analysis